ResMed Inc (RMD)
189.43
+2.49
(+1.33%)
USD |
NYSE |
Jul 02, 09:46
ResMed Net Income (Annual): 897.56M for June 30, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
June 30, 2023 | 897.56M |
June 30, 2022 | 779.44M |
June 30, 2021 | 474.50M |
June 30, 2020 | 621.67M |
June 30, 2019 | 404.59M |
June 30, 2018 | 315.59M |
June 30, 2017 | 342.28M |
June 30, 2016 | 352.41M |
June 30, 2015 | 352.89M |
June 30, 2014 | 345.27M |
June 30, 2013 | 307.13M |
June 30, 2012 | 254.85M |
June 30, 2011 | 226.99M |
June 30, 2010 | 190.08M |
June 30, 2009 | 146.45M |
June 30, 2008 | 110.30M |
Date | Value |
---|---|
June 30, 2007 | 66.30M |
June 30, 2006 | 88.21M |
June 30, 2005 | 64.78M |
June 30, 2004 | 57.28M |
June 30, 2003 | 45.73M |
June 30, 2002 | 37.51M |
June 30, 2001 | 11.63M |
June 30, 2000 | 22.23M |
June 30, 1999 | 16.10M |
June 30, 1998 | 10.60M |
June 30, 1997 | 7.50M |
June 30, 1996 | 4.50M |
June 30, 1995 | 2.80M |
June 30, 1994 | 1.20M |
June 30, 1993 | 0.80M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
474.50M
Minimum
2021
897.56M
Maximum
2023
693.29M
Average
700.56M
Median
Net Income (Annual) Benchmarks
Boston Scientific Corp | 1.593B |
Align Technology Inc | 445.05M |
Haemonetics Corp | 117.56M |
Inspire Medical Systems Inc | -21.15M |
Abbott Laboratories | 5.723B |